April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Biocompatibility and Retention of Activity of Melimine Antimicrobial Contact Lenses in a Human Clinical Trial
Author Affiliations & Notes
  • Debarun Dutta
    School of Optometry and Vision Science, University of New South Wales, sydney, NSW, Australia
    Brien Holden Vision Institute, Sydney, NSW, Australia
  • Jerome Ozkan
    School of Optometry and Vision Science, University of New South Wales, sydney, NSW, Australia
    Brien Holden Vision Institute, Sydney, NSW, Australia
  • Mark D P Willcox
    School of Optometry and Vision Science, University of New South Wales, sydney, NSW, Australia
  • Footnotes
    Commercial Relationships Debarun Dutta, None; Jerome Ozkan, None; Mark Willcox, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4647. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Debarun Dutta, Jerome Ozkan, Mark D P Willcox; Biocompatibility and Retention of Activity of Melimine Antimicrobial Contact Lenses in a Human Clinical Trial. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4647.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Covalent immobilisation of antimicrobial peptide melimine onto contact lenses can produce broad spectrum antimicrobial lenses. The aim of this study was to investigate the performance of melimine-coated contact lenses in a human clinical trial.

Methods: Melimine was covalently attached to the contact lens surface (etafilcon A) via EDC coupling. A prospective, randomised, double-masked, contralateral,1 day clinical trial was used to evaluate subjective responses and ocular physiology during contralateral wear of melimine-coated (test) and uncoated (control) lenses. Delayed reactions were monitored during follow-up visits after 1 and 4 weeks. Ex-vivo retention of antimicrobial activity of worn lenses were assessed by reduction in numbers of viable Pseudomonas aeruginosa 6294 and Staphylococcus aureus 31.

Results: No differences were observed in wettability and surface deposition between test and control lenses (p >0.05). Lens fitting centration, movement, tightness, and corneal coverage were comparable between the test and control lenses. There were no significant differences between test and control lenses for bulbar, limbal or palpebral redness or conjunctival staining (p >0.05). Mean corneal (extent, depth and type) staining was higher for test lenses compared to control lenses (p< 0.05). There was no difference in subjective responses for lens comfort, dryness and awareness (p< 0.05). No delayed reactions were associated with the test lenses. Worn test lenses retained more than 1.5 log inhibition against both bacterial types.

Conclusions: This study provides the first evidence to indicate antimicrobial peptide-coated contact lenses can be worn safely by humans. Melimine-coated lens wear was uneventful except that it was associated with higher corneal staining, similar in presentation to solution-induced corneal staining (extent and depth). The melimine-coated lenses retained high antibacterial activity following wear.

Keywords: 477 contact lens • 422 antibiotics/antifungals/antiparasitics • 464 clinical (human) or epidemiologic studies: risk factor assessment  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×